Bacterial co‐infections with SARS‐CoV‐2

R Mirzaei, P Goodarzi, M Asadi, A Soltani… - IUBMB …, 2020 - Wiley Online Library
The pandemic coronavirus disease 2019 (COVID‐19), caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS‐CoV‐2), has affected millions of people worldwide. To …

[HTML][HTML] The find of COVID-19 vaccine: Challenges and opportunities

M ElBagoury, MM Tolba, HA Nasser, A Jabbar… - Journal of infection and …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus (SARS-CoV-2), a novel corona virus,
causing COVID-19 with Flu-like symptoms is the first alarming pandemic of the third …

Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

AD Bendala Estrada, J Calderón Parra… - BMC infectious …, 2021 - Springer
Abstract Background Since December 2019, the COVID-19 pandemic has changed the
concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to …

ESKAPE and beyond: the burden of coinfections in the COVID-19 pandemic

MÁ Loyola-Cruz, LU Gonzalez-Avila, A Martínez-Trejo… - Pathogens, 2023 - mdpi.com
The ESKAPE group constitute a threat to public health, since these microorganisms are
associated with severe infections in hospitals and have a direct relationship with high …

High mortality from viral pneumonia in patients with cancer

YJ Kim, ES Lee, YS Lee - Infectious Diseases, 2019 - Taylor & Francis
Background: With the advancement of diagnostic methods, a viral infection is increasingly
recognized in adult patients with pneumonia and the outcomes can be fatal especially in …

Aetiology and prognosis of community-acquired pneumonia at the Adult University Teaching Hospital in Zambia

LM Ziko, TW Hoffman, S Fwoloshi, D Chanda… - Plos one, 2022 - journals.plos.org
Background Community-acquired pneumonia (CAP) is a frequent cause of death worldwide,
and in sub-Saharan Africa particularly. Human immunodeficiency virus infection (HIV) and …

Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic

V Kumar, N Yasmeen, AA Chaudhary… - Frontiers in molecular …, 2023 - frontiersin.org
The most severe clinical manifestations of the horrifying COVID-19 disease, that claimed
millions of lives during the pandemic time, were Acute respiratory distress syndrome …

[HTML][HTML] Safety and immunogenicity of a respiratory syncytial virus prefusion F protein (RSVPreF3) candidate vaccine in older Japanese adults: A phase I, randomized …

S Kotb, M Haranaka, N Folschweiller… - Respiratory …, 2023 - Elsevier
Background Respiratory syncytial virus (RSV) causes lower respiratory tract infection, with a
high burden of disease among adults≥ 60 years. This study assessed the safety …

[HTML][HTML] Psychiatric hospitalizations by the Unified Health System in Brazil between 2000 and 2014

HA Rocha, IA Reis, MAC Santos, APS Melo… - Revista de Saúde …, 2021 - SciELO Brasil
ABSTRACT OBJECTIVE To characterize the profile of patients hospitalized for mental and
behavioral disorders by the Unified Health System (SUS) in Brazil between 2000 and 2014 …

Targeted literature review of the burden of respiratory syncytial infection among high-risk and elderly patients in Asia Pacific region

D Kurai, JY Song, YC Huang, Z Jie, P Atanasov… - Infectious diseases and …, 2023 - Springer
Introduction The burden of respiratory syncytial virus (RSV), which causes acute respiratory
illness, is well recognized among the pediatric population but also imposes a significant risk …